From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

JPM-TMT Seeks Solutions to Multi-Drug Resistant Biowarfare Agents

by Global Biodefense Staff
March 12, 2013

Yersinia pestis (Plague)The U.S. Department of Defense has initiated a new research and development effort to address the continuing emergence of multi-drug resistant bacteria and advancements in biotechnology that enable development of genetically engineered, drug-resistant bacteria. 

To address the potential weaponization of multi-drug resistant biological warfare agents the Joint Project Manager Transformational Medical Technologies (JPM-TMT) has issued a Request for Information (RFI) for therapeutic solutions including development of: 

  • Novel combinations of existing FDA-approved therapeutics that act synergistically
  • Adjunctive molecules that interfere with antibiotic resistance mechanisms
  • Novel therapeutic compounds for which there is no known bacterial resistance 

Medical countermeasures against Yersinia pestis, Brucella, Francisella tularensis, Burkholderia mallei and pseudomallei are specifically sought. 

The effort is spearheaded by JPM-TMT’s provisional Countermeasures for Multi-Drug Resistance—Bacterial (CMDR-B) program. Further details are available under Solicitation Number: HDTRA1-RFI-TMT01. The response deadline is May 17, 2013. 

Source: JPM-TMT, FBO.gov 

Image: Dark stained bipolar ends of Yersinia pestis can clearly be seen in this Wright’s stain of blood from a plague victim (CDC)

From Our Partners
Tags: AntimicrobialsBrucellaBurkholderiaDefense Threat Reduction AgencyF. tularensisJPEO-CBRNDRFIY. pestis

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC